MENU
+Compare
LTRN
Stock ticker: NASDAQ
AS OF
May 30 closing price
Price
$3.05
Change
-$0.08 (-2.56%)
Capitalization
33.16M

LTRN Lantern Pharma Forecast, Technical & Fundamental Analysis

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development... Show more

LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for LTRN with price predictions
May 30, 2025

LTRN sees MACD Histogram just turned negative

LTRN saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on May 16, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 54 instances where the indicator turned negative. In of the 54 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for LTRN moved out of overbought territory on May 08, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 similar instances where the indicator moved out of overbought territory. In of the 21 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on May 16, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on LTRN as a result. In of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

LTRN moved below its 50-day moving average on May 20, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for LTRN crossed bearishly below the 50-day moving average on May 27, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LTRN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

LTRN broke above its upper Bollinger Band on May 07, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LTRN advanced for three days, in of 233 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 89 cases where LTRN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.961) is normal, around the industry mean (16.282). P/E Ratio (0.000) is within average values for comparable stocks, (59.459). LTRN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.224). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (270.467).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. LTRN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LTRN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

LTRN is expected to report earnings to fall 1.85% to -52 cents per share on August 06

Lantern Pharma LTRN Stock Earnings Reports
Q2'25
Est.
$-0.53
Q4'24
Beat
by $0.05
Q3'24
Beat
by $0.14
Q2'24
Beat
by $0.09
Q1'24
Missed
by $0.08
The last earnings report on March 27 showed earnings per share of -54 cents, beating the estimate of -58 cents. With 37.69K shares outstanding, the current market capitalization sits at 33.16M.
A.I. Advisor
published General Information

General Information

a company, which engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1920 McKinney Avenue
Phone
+1 972 277-1136
Employees
21
Web
https://www.lanternpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ORRF30.060.13
+0.43%
Orrstown Financial Services
KIRK1.07N/A
N/A
Kirkland's
AME178.74-1.30
-0.72%
Ametek
HE10.68-0.19
-1.75%
Hawaiian Electric Industries
HRI124.00-4.30
-3.35%
Herc Holdings

LTRN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LTRN has been loosely correlated with AXON. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LTRN jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LTRN
1D Price
Change %
LTRN100%
-2.56%
AXON - LTRN
36%
Loosely correlated
+2.75%
MNMD - LTRN
34%
Loosely correlated
N/A
ABSI - LTRN
34%
Loosely correlated
-3.28%
GLYC - LTRN
34%
Loosely correlated
-1.55%
DNA - LTRN
34%
Loosely correlated
-4.14%
More